Trials / Completed
CompletedNCT01578382
Pathophysiology of Martorell Hypertensive Ischemic Leg Ulcer (HYTILU)
Pathophysiology of Martorell Hypertensive Ischemic Leg Ulcer (HYTILU): A Comparison of Martorell HYTILU, Calciphylaxis and Venous Ulcer (Control)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 20 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Martorell hypertensive ischemic leg ulcer is a severe type of skin necrosis (skin infarction) which occurs in long-term hypertensive subjects. Calciphylaxis (calcific uremic arteriolopathy) is a severe type of skin necrosis (skin infarction) which occurs in subjects with end-stage kidney disease or after kidney transplantation.
Detailed description
Comparative study including * 20 consecutive patients with Martorell HYTILU * 10 consecutive patients with Calciphylaxis (calcific uremic arteriolopathy) * 20 patients with venous ulcer The following parameters are measured in the blood serum: White blood count; c-reactive protein; creatinine; calcium (total); free (ionized) calcium; phosphate; albumin; 25-hydroxyvitamin-D; 1-25-dihydroxyvitamin-D; homocysteine; cystatin C alphafetoin, osteoprotegerin; fibroblast growth factor 23 (FGF-23); globular arrest 1 (GLA-1) The following parameters are measured in samples of diseased (necrobiotic) skin: alphafetoin, osteoprotegerin; fibroblast growth factor 23 (FGF-23); globular arrest 1 (GLA-1)
Conditions
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2012-04-16
- Last updated
- 2021-06-18
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01578382. Inclusion in this directory is not an endorsement.